Embattled drugmaker Mylan — which on Monday announced a cheaper, generic version of the EpiPen — has been funneling cash to lawmakers who are weighing whether to launch hearings into its sky high prices, The Post has learned. Sen. Charles Schumer has landed $10,000 in combined campaign contributions from Mylan CEO Heather Bresch and the...